Private Asset Management’s AbbVie ABBV Stock Holding History

Private Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$643K	Sell	4,315 -500	-10%	-$73.4K	0.15%	78
2023 Q2	$649K	Sell	4,815 -676	-12%	-$99.1K	0.12%	81
2023 Q1	$875K	Sell	5,491 -200	-4%	-$30.6K	0.14%	81
2022 Q4	$920K	Hold	5,691	–	–	0.16%	76
2022 Q3	$764K	Sell	5,691 -1	-0%	-$143	0.14%	81
2022 Q2	$872K	Sell	5,692 -115	-2%	-$17.6K	0.14%	80
2022 Q1	$941K	Sell	5,807 -956	-14%	-$139K	0.13%	84
2021 Q4	$916K	Sell	6,763 -60	-0.9%	-$7.09K	0.11%	85
2021 Q3	$736K	Hold	6,823	–	–	0.1%	94
2021 Q2	$769K	Sell	6,823 -400	-6%	-$45K	0.1%	92
2021 Q1	$782K	Buy	7,223 +340	+5%	+$36.4K	0.11%	88
2020 Q4	$738K	Buy	6,883 +400	+6%	+$38.4K	0.11%	84
2020 Q3	$568K	Sell	6,483 -88	-1%	-$8.29K	0.09%	89
2020 Q2	$645K	Sell	6,571 -2	-0%	-$176	0.11%	85
2020 Q1	$501K	Sell	6,573 -450	-6%	-$38.3K	0.11%	86
2019 Q4	$622K	Sell	7,023 -2,213	-24%	-$184K	0.1%	89
2019 Q3	$699K	Hold	9,236	–	–	0.12%	85
2019 Q2	$672K	Buy	9,236 +130	+1%	+$10.2K	0.11%	85
2019 Q1	$734K	Sell	9,106 -200	-2%	-$16.4K	0.13%	81
2018 Q4	$858K	Sell	9,306 -100	-1%	-$8.79K	0.17%	75
2018 Q3	$890K	Hold	9,406	–	–	0.14%	82
2018 Q2	$871K	Buy	9,406 +156	+2%	+$15.2K	0.14%	88
2018 Q1	$876K	Buy	9,250 +94	+1%	+$10.3K	0.15%	76
2017 Q4	$885K	Sell	9,156 -4,700	-34%	-$443K	0.14%	80
2017 Q3	$1.23M	Hold	13,856	–	–	0.2%	75
2017 Q2	$1M	Hold	13,856	–	–	0.16%	78
2017 Q1	$903K	Sell	13,856 -200	-1%	-$12.6K	0.15%	83
2016 Q4	$880K	Sell	14,056 -180	-1%	-$11K	0.15%	82
2016 Q3	$898K	Buy	14,236 +300	+2%	+$19.4K	0.15%	86
2016 Q2	$863K	Hold	13,936	–	–	0.15%	82
2016 Q1	$796K	Hold	13,936	–	–	0.14%	83
2015 Q4	$826K	Hold	13,936	–	–	0.15%	83
2015 Q3	$758K	Buy	13,936 +4,700	+51%	+$306K	0.14%	85
2015 Q2	$621K	Buy	9,236 +240	+3%	+$15.7K	0.1%	89
2015 Q1	$527K	Buy	8,996 +1,000	+13%	+$60.4K	0.09%	96
2014 Q4	$523K	Hold	7,996	–	–	0.08%	93
2014 Q3	$462K	Buy	7,996 +1,000	+14%	+$55.5K	0.07%	101
2014 Q2	$395K	Sell	6,996 -135	-2%	-$7.08K	0.06%	104
2014 Q1	$367K	Hold	7,131	–	–	0.06%	106
2013 Q4	$377K	Sell	7,131 -80	-1%	-$3.93K	0.06%	105
2013 Q3	$323K	Sell	7,211 -2,812	-28%	-$125K	0.06%	102
2013 Q2	$414K	Buy	+10,023	New	+$438K	0.08%	98

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Private Asset Management's ABBV Position: Q3 2023 in Review

Private Asset Management reduced its AbbVie (ABBV) stake by 10% in Q3 2023, selling an estimated $73.4K and leaving 4,315 shares worth $643K. The position accounts for 0.15% of the portfolio, ranked #78.

Private Asset Management first reported a position in ABBV in Q2 2013 and has held it in 42 quarters since. The position peaked at $1.23M in Q3 2017. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

Private Asset Management held 4,315 shares of AbbVie worth $643K as of Q3 2023.
Private Asset Management sold 500 AbbVie shares in Q3 2023, an estimated $73.4K.
AbbVie made up 0.15% of Private Asset Management's portfolio in Q3 2023, its #78 holding.
Private Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 42 quarters since.
Private Asset Management's AbbVie position peaked at $1.23M in Q3 2017.
3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Private Asset Management's 13F filing for Q3 2023, filed 20 Oct 2023.